PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2052
https://www.valueinhealthjournal.com/article/S1098-3015(12)03765-5/fulltext
Title : PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03765-5&doi=10.1016/j.jval.2012.08.2052
First page : A569
Section Title : Sensory Systems Disorders
Open access? : No
Section Order : 1538
Categories :
Tags :
Regions :
ViH Article Tags :